EU: Veru Inc (VERU) Stock Has Just Had Its “Buy” Rating Reiterated by H.C. Wainwright. Shares now Have a $5.0000 Target

May 18, 2018 - By Migdalia James

Veru Inc (VERU) Rating Reaffirmed

Veru Inc (VERU) just had their share rating of a ‘”Buy”‘ issued by research analysts at H.C. Wainwright, who now has a $5.0000 target on the $95.79M market cap company or a 179.33 % upside potential. This key information was revealed in an analyst report on 18 May.

The stock increased 0.56% or $0.01 during the last trading session, reaching $1.79. About 11,367 shares traded. Veru Inc. (VERU) has risen 64.49% since May 18, 2017 and is uptrending. It has outperformed by 52.94% the S&P500.

Analysts await Veru Inc. (NASDAQ:VERU) to report earnings on August, 14. They expect $-0.05 earnings per share, down 66.67 % or $0.02 from last year’s $-0.03 per share. After $-0.07 actual earnings per share reported by Veru Inc. for the previous quarter, Wall Street now forecasts -28.57 % EPS growth.

Veru Inc. operates as a urology and oncology biopharmaceutical company. The company has market cap of $95.79 million. The firm operates through two divisions, Commercial; and Research and Development. It currently has negative earnings. It offers FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus; and PREBOOST benzocaine medicated individual wipes for the prevention of premature ejaculation.

More notable recent Veru Inc. (NASDAQ:VERU) news were published by: which released: “Veru’s (VERU) CEO Mitchell Steiner on Q2 2018 Results – Earnings Call Transcript” on May 09, 2018, also with their article: “Veru Reports Fiscal 2018 Second-Quarter Financial Results” published on May 09, 2018, published: “Veru, Inc. (VERU) Reports Publication of Data on Oral VERU-111 in Prostate Cancer at 2018 ASCO” on May 17, 2018. More interesting news about Veru Inc. (NASDAQ:VERU) were released by: and their article: “Veru to Report Fiscal 2018 Second-Quarter Financial Results, Host Conference Call on May 9th” published on May 03, 2018 as well as‘s news article titled: “Veru Announces Publication of Data from Three Cancer Studies as Part of the Upcoming American Society of Clinical …” with publication date: May 17, 2018.

Veru Inc. (NASDAQ:VERU) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.